BIO Protocol is a platform designed to revolutionize the funding and commercialization of decentralized science (DeSci), unlocking innovation in biotech and improving access to science funding.
Empowering Global Communities
BIO connects patients, scientists, and biotech investors, enabling them to collectively fund, develop, and co-own tokenized biotech projects and intellectual property (IP).
Challenges in Scientific Funding
1. Time-Consuming Processes
Scientists spend up to 80% of their time applying for funding, reducing time for critical research.
2. The Valley of Death
Early-stage discoveries often fail to reach commercialization due to resource gaps, high risks, and insufficient support.
3. Funding Concentration
A significant portion of scientific funding is concentrated in specific regions, leaving much of the world’s talent untapped.
4. IP and Licensing Barriers
Fragmented IP ownership and complex licensing agreements hinder collaboration and slow the commercialization of innovations.
5. Limited Patient Access
Research is often disconnected from patient communities, leading to misaligned priorities.
How BIO Protocol Solves These Problems-
1. Decentralized Funding
Opens biotech investment to anyone, democratizing access to opportunities.
2. Capital Efficiency
Aggregates resources like patient data, funding, and labor to reduce the cost of innovation.
3. Diversified Portfolios
Bundles multiple biotech projects to lower investment risk through diversification.
4. Global Talent and Capital Pool
Engages a worldwide network of scientists, researchers, and investors to collaborate on therapeutic or drug-focused initiatives.
5. Shared IP Ownership
Introduces tokenized co-ownership of Biotech DAOs and scientific IP.
6. Liquid Markets
Offers liquidity for traditionally illiquid biotech assets.
7. Open Access
Eliminates gatekeeping in funding and decision-making for scientific research.
BIO Token Utility: The BIO token powers the BIO Protocol ecosystem with the following functionalities:
1. Governance
Grants token holders the ability to vote on protocol decisions and meta-governance across BioDAOs.
2. Whitelisted Access:
Provides exclusive access to BioDAO funding rounds and tokenized IP opportunities.
3. Curation:
Allows holders to decide which BioDAOs are launched via the BIO Launchpad, with support for funding and liquidity.
4. Network BioDAOs
Represents a collective of DeSci tokens, as BioDAOs contribute a portion of their initial token supply to the network in exchange for funding and acceleration services.
5. Protocol-Owned Liquidity (POL)
BIO Protocol earns trading fees by providing liquidity for BioDAO and IP tokens in its treasury.
BIO Protocol has successfully completed several private and public financing rounds, positioning itself as a leader in the DeSci and biotech innovation space.
Price prediction to be around 1$ at launch
